Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Cash Flows

Condensed Consolidated Statement of Cash Flows
9 Months Ended
Sep. 30, 2021
USD ($)
Cash Flows from Operating Activities:  
Net (loss) $ (854,214)
Adjustments to reconcile net loss to net cash used in operating activities:  
Change in fair value of warrant liabilities (922,550)
Interest earned on investments held in Trust Account (14,504)
Transaction costs associated with initial public offering 234,419
Changes in operating assets and liabilities:  
Prepaid expenses (255,960)
Accounts payable and accrued expenses 372,616
Net cash used in operating activities (1,440,193)
Cash Flows from Investing Activities:  
Investment of cash into trust Account (316,250,000)
Net cash used in investing activities (316,250,000)
Cash Flows from Financing Activities:  
Proceeds from sale of Units 309,924,999
Proceeds from sale of Private Placement Unit 8,325,000
Repayment of promissory note – related party (275,000)
Payment of offering costs, including underwriting discount (367,028)
Net cash provided by financing activities 317,607,971
Net Change in Cash (82,222)
Cash – Beginning of period 179,512
Cash – End of period 97,290
Non-Cash investing and financing activities:  
Offering costs included in accrued offering costs 15,450
Initial classification of Class A common stock subject to possible redemption $ 316,250,000